Arrowhead Pharmaceuticals (ARWR) Capital Expenditures (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) recorded Capital Expenditures of $3.85 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 63.0% from $2.36 million a year earlier and up 50.3% from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Capital Expenditures (2011 - 2026) Analysis & Trends
On a TTM basis, Arrowhead Pharmaceuticals' Capital Expenditures came in at $16.09 million as of Jun 30, 2026, down 59.2% year-over-year; for FY2025 (ended Sep 30, 2025), it was $22.7 million, down 84.0% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 13.7% (FY2020 to FY2025).
- Across earlier fiscal years, Capital Expenditures came in at $141.47 million in FY2024 (-20.0%), $176.74 million in FY2023 (+234.9%), $52.78 million in FY2022 (+123.9%) and $23.57 million in FY2021 (+97.2%).
- Quarterly Capital Expenditures has ranged from $2.15 million in fiscal Q1 2026 to $68.66 million in fiscal Q1 2024 over the past five years.
- On a year-over-year basis, Capital Expenditures rose in 1 of the last eight quarters, with an average decline of 56.0%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 573.4% in fiscal Q1 2023, against a decline of 89.1% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $2.57 million (Q2 2026), $2.15 million (Q1 2026) and $7.52 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Arrowhead Pharmaceuticals | 9.35 Bn | 4.13 Bn | - | 3.85 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.85 Mn |
| Mar 31, 2026 | 2.57 Mn |
| Dec 31, 2025 | 2.15 Mn |
| Sep 30, 2025 | 7.52 Mn |
| Jun 30, 2025 | 2.36 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 7.52 Mn |
| Sep 30, 2024 | 24.29 Mn |
| Jun 30, 2024 | 14.45 Mn |
| Mar 31, 2024 | 34.08 Mn |
| Dec 31, 2023 | 68.66 Mn |
| Sep 30, 2023 | 63.91 Mn |
| Jun 30, 2023 | 46.61 Mn |
| Mar 31, 2023 | 27.31 Mn |
| Dec 31, 2022 | 38.91 Mn |
| Sep 30, 2022 | 32.71 Mn |
| Jun 30, 2022 | 9.54 Mn |
| Mar 31, 2022 | 4.75 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 8.20 Mn |
Arrowhead Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();